Nasdaq 100 Stocks Performance Guide: Vertex Pharmaceuticals Inc (VRTX)
VRTX has no dividends
Table and Chart of VRTX Performance
See what a $1,000 investment in VRTX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| VRTX Returns | |
|---|---|
| Start Date | Nov-29-2013 |
| Start Price | $69.42 |
| End Date | Nov-29-2023 |
| End Price | $351.00 |
| # Prices | 121 |
| Min Date | Apr-30-2014 |
| Min Price | $67.70 |
| Max Date | Oct-31-2023 |
| Max Price | $362.11 |
| Total Return | 405.62% |
| Annualized Return | 17.44% |
| Current Value of $1,000 Purchase | $5,056 |
| Number Returns | 7,260 |
| Average Return | 80.71% |
| Number Profitable Returns | 6,461 |
| Percent Profitable Returns | 88.99% |
| Number Unprofitable Returns | 799 |
| Percent Unprofitable Returns | 11.01% |
| Profitable to Unprofitable Returns Ratio | 8.09 |
| VRTX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $89,426,313,000 | Price to Sales | 9.26 |
| Earnings per Share | $13.3300 |
| PE Ratio | 26.03 |
| PE to Growth Ratio | 0.491 |
| Price to Book | 5.42 |
| PRICE DATA | |
| 52 Week High | $387.42 |
| 52 Week Low | $282.21 |
| Analyst Target Price | $400 |
| 50-Day Moving Average | $360.87 |
| 200-Day Moving Average | $339.22 |
| FINANCIAL DATA | |
| Revenue per Share | $37.49 |
| Revenue | $9,654,200,000 |
| Profit Margin | 35.9% |
| Return on Equity | 0.235% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
VRTX Compare Returns with S&P 500
VRTX Trendline Chart